Search hospitals > Minnesota > Duluth
Essentia Health Saint Mary's Medical Center
Claim this profileDuluth, Minnesota 55805
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
212 reported clinical trials
3 medical researchers
Summary
Essentia Health Saint Mary's Medical Center is a medical facility located in Duluth, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Essentia Health Saint Mary's Medical Center is involved with conducting 212 clinical trials across 389 conditions. There are 3 research doctors associated with this hospital, such as Bret E. Friday, Catherine Benziger, MD, MPH, and Bret EB Friday.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Bret E. FridayEssentia Health Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
109 reported clinical trials
180 drugs studied
Catherine Benziger, MD, MPHEssentia Health1 year of reported clinical research
Studies Cardiovascular Disease
Studies High Cholesterol
4 reported clinical trials
6 drugs studied
Bret EB FridayEssentia Health - Deer River Clinic5 years of reported clinical research
Studies Glioblastoma
Studies Cognitive Impairment
2 reported clinical trials
1 drug studied
Clinical Trials running at Essentia Health Saint Mary's Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Bladder Cancer
Cancer
Cutaneous Melanoma
Melanoma
Renal Cell Carcinoma
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Essentia Health Saint Mary's Medical Center?
Essentia Health Saint Mary's Medical Center is a medical facility located in Duluth, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Essentia Health Saint Mary's Medical Center is involved with conducting 212 clinical trials across 389 conditions. There are 3 research doctors associated with this hospital, such as Bret E. Friday, Catherine Benziger, MD, MPH, and Bret EB Friday.